Morbidity of Temporary Loop Ileostomy in Patients with Colorectal Cancer.

Single-celled organisms colonize biotic and abiotic surfaces via intrinsic mechanisms that differentiate them from free-floating bacteria. The vital role of these mechanisms is in communication and survival in challenging environments. Particularly concerning are the biofilms formed by bacteria, which pose substantial challenges in diverse settings, ranging from medical implants to industrial pipelines. Therefore, understanding the underlying mechanisms driving biofilm formation is essential as a foundational step in devising strategies to curb or prevent their growth. The rationale behind conducting this review study is to comprehensively address the intricate issue of bacterial biofilm formation and its far-reaching implications across various domains of human life and healthcare. Bacteria within biofilms exhibit complex multicellular behaviors, orchestrated through quorum sensing, which finely regulates gene expressions. This collective behavior fundamentally transforms the traditional perception of microbes, as they navigate three-dimensional colonization, evolve, allocate responsibilities within the biofilm consortium, and adapt to varying environmental conditions. Furthermore, the escalating crisis of antibiotic resistance in bacteria presents formidable challenges in treating biofilm-associated infections such as urinary tract infections, bacterial prostatitis, chronic otitis media, lung infections, etc. Conventional antibiotics, historically effective against bacterial infections, now falter in the face of biofilm-related ailments. Hence, the pressing need to deepen our comprehension of bacterial biofilms becomes evident. Considering all this, this review will provide insight into the biofilm formation, and intercellular communication within biofilm communities, as well as their survival and socializing strategies. We also address the pressing challenge of antibiotic resistance which has emerged as a major obstacle in healthcare. Therefore, it is critical and urgent for clinicians to effectively treat biofilm-mediated infections with antibiotics that are now accessible. To achieve this, a collaborative approach involving microbiologists, chemists, and clinicians is essential to develop novel nanoparticle-based therapeutics and preventive strategies to effectively target and eradicate biofilms. In Short, our goal is to improve patient management and address the root cause of several chronic diseases that are often exacerbated by biofilm infections.